Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniela Frigerio"'
Autor:
Alen Zabotti, Michele Maria Luchetti, Carlo Francesco Selmi, Roberta Ramonda, Rosa Daniela Grembiale, Lorenzo Dagna, Salvatore D'Angelo, Giacomo Cafaro, Salvatore De Vita, Mara Felicetti, Silvia Marelli, Daniela Frigerio, Ennio Giulio Favalli
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: Data about the clinical presentation and management of early and mild spondyloarthritis (SpA) are limited.Objectives: The objective of this study was to describe the baseline characteristics of disease-modifying antirheumatic drug (DMAR
Externí odkaz:
https://doaj.org/article/09ea1d17bdaa4ce2aef44525df025b19
Autor:
Ottavio Secchi, Ivana Bravatà, Daniela Frigerio, Alessia Brigido, Antonio Rispo, Flavio Caprioli, Marco Daperno
Publikováno v:
European Journal of Gastroenterology & Hepatology. 33:1082-1090
Objectives Anti-TNFα agents have been a staple of Crohn's disease treatment for 20 years, but they have weaknesses. New treatments have more recently become available. The aim of this paper is to examine the Crohn's disease patient population for wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c14fcbe1532d8b6e7b751cb6bea6442
https://doi.org/10.1097/meg.0000000000002183
https://doi.org/10.1097/meg.0000000000002183
Autor:
Michele Maria Luchetti, Roberta Ramonda, Mara Felicetti, Silvia Marelli, Alen Zabotti, Ennio Giulio Favalli, Giacomo Cafaro, Rosa Daniela Grembiale, Salvatore D'Angelo, L. Dagna, S. De Vita, Carlo Selmi, Daniela Frigerio
Publikováno v:
Annals of the Rheumatic Diseases. 80:809-809
Background:Limited data on early Psoriatic Arthritis (PsA) are available1,2.Objectives:To describe baseline data of PsA patients naive to any DMARDs.Methods:SIRENA study is an Italian, prospective Registry of Spondyloarthritis patients diagnosed acco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44a59d89699187b68815f8e890296c85
https://doi.org/10.1136/annrheumdis-2021-eular.607
https://doi.org/10.1136/annrheumdis-2021-eular.607
Autor:
Maurizio Lucchini, Myriam Maillard, Adriano Lazzarin, Daniela Frigerio, Mauro Moroni, G P Rizzardi, Massimo Musicco
Publikováno v:
Journal of Infection. 31:99-105
The aim of this multicentric randomised controlled trial was to evaluate long-term efficacy and safety of once-monthly versus twice-monthly 300 mg aerosolised pentamidine (AP) as secondary prophylaxis of Pneumocystis carinii pneumonia (PCP). We rando
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9567c4e9465e513462581e0223b7304
https://doi.org/10.1016/s0163-4453(95)92035-8
https://doi.org/10.1016/s0163-4453(95)92035-8